Jazz Pharmaceuticals (JAZZ) keeps soaring, now up 15.4% premarket after AH strength, on the...

|About: Jazz Pharmaceuticals, Inc. (JAZZ)|By:, SA News Editor

Jazz Pharmaceuticals (JAZZ) keeps soaring, now up 15.4% premarket after AH strength, on the heels of landing EUSA Pharma and its leukemia drug for a cool $700M. The deal gives the company a larger global footprint.